Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Russell Inv Equity Income C REQSX
- NAV / 1-Day Return 24.57 / +1.28 %
- Total Assets 189.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.870%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment —
- Status Open
- TTM Yield 0.63%
- Turnover 31%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 11:00 PM GMT+0
Morningstar’s Analysis REQSX
Will REQSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
E-mini S&P 500 Future Sept 24 | 5.92 | 11.9 Mil | — |
U.S. Cash Management Fund | 5.72 | 11.5 Mil | Cash and Equivalents |
JPMorgan Chase & Co | 2.39 | 4.8 Mil | Financial Services |
Berkshire Hathaway Inc Class B | 1.65 | 3.3 Mil | Financial Services |
CVS Health Corp | 1.53 | 3.1 Mil | Healthcare |
Citigroup Inc | 1.49 | 3.0 Mil | Financial Services |
Merck & Co Inc | 1.48 | 3.0 Mil | Healthcare |
Wells Fargo & Co | 1.36 | 2.7 Mil | Financial Services |
Philip Morris International Inc | 1.36 | 2.7 Mil | Consumer Defensive |
Medtronic PLC | 1.21 | 2.4 Mil | Healthcare |